News

Here you will find all the news about our companies. We keep you informed about our latest events, our publications, our partnerships and our progress in terms of R&D…

FDA event: PBPK best practices

FDA event: PBPK best practices

We participated at the FDA workshop about the development of Best Practices in Physiologically Based Pharmacokinetic Modeling to Support Clinical Pharmacology Regulatory Decision-Making.
Read more
EMA gave a positive opinion about Fexinidazole

EMA gave a positive opinion about Fexinidazole

We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”:
Read more
BioQuébec
Montreal International
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
AFPT